Chi Zhou
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
LRP8-dependent cholesterol metabolism modulates mTORC1 signaling and apoptotic pathways in multiple myeloma.
Journal: Cell death & disease
Published: November 22, 2024
Maintenance therapy promotes profound organ and haematologic response in light-chain amyloidosis patients not undergoing autologous stem cell transplantation.
Journal: Annals of medicine
Published: October 21, 2024
Myeloma cell-derived CXCL7 facilitates proliferation of tumor cells and occurrence of osteolytic lesions through JAK/STAT3 pathway.
Journal: Cell death & disease
Published: October 05, 2024
Early minimal residual disease eradication in light chain amyloidosis generates deeper and faster cardiac response.
Journal: Clinical and experimental medicine
Published: April 19, 2024
Clinical profiles in multiple myeloma patients with extreme survivals: a study from a National Medical Center in China.
Journal: Hematology (Amsterdam, Netherlands)
Published: November 29, 2023
The loss of neoantigens is an important reason for immune escape in multiple myeloma patients with high intratumor heterogeneity.
Journal: Cancer medicine
Published: April 21, 2023
Thrombosis events in Chinese patients with newly diagnosed multiple myeloma.
Journal: Clinical and experimental medicine
Published: February 26, 2023
The evolving diagnosis and treatment paradigms of multiple myeloma in China: 15 years' experience of 1256 patients in a national medical center.
Journal: Cancer medicine
Published: November 09, 2022
Real world outcomes of lenalidomide or bortezomib maintenance in patients with multiple myeloma not undergoing stem cell transplantation.
Journal: Annals of hematology
Published: September 17, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026